80 related articles for article (PubMed ID: 19707761)
21. Chemotherapy for Biliary Tract Cancer in 2021.
Sasaki T; Takeda T; Okamoto T; Ozaka M; Sasahira N
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300274
[TBL] [Abstract][Full Text] [Related]
22. High Response Rate and Prolonged Survival of Unresectable Biliary Tract Cancer Treated With a New Combination Therapy Consisting of Intraarterial Chemotherapy Plus Radiotherapy.
Goto T; Saito H; Sasajima J; Kawamoto T; Fujinaga A; Utsumi T; Yanagawa N; Hiramatsu K; Takamura A; Sato H; Fujibayashi S; Fujiya M
Front Oncol; 2020; 10():597813. PubMed ID: 33312956
[TBL] [Abstract][Full Text] [Related]
23. New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma.
Massironi S; Pilla L; Elvevi A; Longarini R; Rossi RE; Bidoli P; Invernizzi P
Cells; 2020 Mar; 9(3):. PubMed ID: 32168869
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes of previously untreated patients with unresectable intrahepatic cholangiocarcinoma following proton beam therapy.
Shimizu S; Okumura T; Oshiro Y; Fukumitsu N; Fukuda K; Ishige K; Hasegawa N; Numajiri H; Murofushi K; Ohnishi K; Mizumoto M; Nonaka T; Ishikawa H; Sakurai H
Radiat Oncol; 2019 Dec; 14(1):241. PubMed ID: 31881895
[TBL] [Abstract][Full Text] [Related]
25. Precision surgery for primary liver cancer.
Takamoto T; Makuuchi M
Cancer Biol Med; 2019 Aug; 16(3):475-485. PubMed ID: 31565478
[TBL] [Abstract][Full Text] [Related]
26. The Efficacy of Different Chemotherapy Regimens for Advanced Biliary Tract Cancer: A Systematic Review and Network Meta-Analysis.
Li Y; Zhou Y; Hong Y; He M; Wei S; Yang C; Zheng D; Liu F
Front Oncol; 2019; 9():441. PubMed ID: 31192137
[No Abstract] [Full Text] [Related]
27. Pathologic complete response after gemcitabine and S-1 chemotherapy for far advanced intrahepatic cholangiocarcinoma.
Tatsuguchi T; Gotoh K; Kobayashi S; Asukai K; Tomokuni A; Akita H; Wada H; Takahashi H; Ohue M; Yano M; Sakon M
Int Cancer Conf J; 2018 Jul; 7(3):93-97. PubMed ID: 31149523
[TBL] [Abstract][Full Text] [Related]
28. The Efficacy and Safety of First-line Chemotherapies for Advanced Biliary Tract Cancer: A Network Meta-analysis.
Zheng W; Ying J; Zhou Y; Lu Z; Min K; Wang W; Zhang Y; Zhang M; Yang J
J Cancer; 2019; 10(1):257-266. PubMed ID: 30662546
[TBL] [Abstract][Full Text] [Related]
29. Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases.
Takahara N; Nakai Y; Isayama H; Sasaki T; Saito K; Oyama H; Kanai S; Suzuki T; Sato T; Hakuta R; Ishigaki K; Takeda T; Saito T; Mizuno S; Kogure H; Tada M; Koike K
Invest New Drugs; 2018 Dec; 36(6):1093-1102. PubMed ID: 30324343
[TBL] [Abstract][Full Text] [Related]
30. Gemcitabine and S-1 versus gemcitabine and cisplatin treatment in patients with advanced biliary tract cancer: a multicenter retrospective study.
Takahara N; Isayama H; Nakai Y; Sasaki T; Ishigaki K; Saito K; Akiyama D; Uchino R; Mizuno S; Yagioka H; Kogure H; Togawa O; Matsubara S; Ito Y; Toda N; Tada M; Koike K
Invest New Drugs; 2017 Jun; 35(3):269-276. PubMed ID: 28124197
[TBL] [Abstract][Full Text] [Related]
31. Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine/cisplatin/S-1 combination chemotherapy: A case report.
Matsubara T; Nishida T; Tomimaru Y; Yamamoto M; Hayashi S; Nakajima S; Fukui K; Dono K; Adachi S; Ioka T; Kanai M; Inada M
Mol Clin Oncol; 2016 Dec; 5(6):757-761. PubMed ID: 28101354
[TBL] [Abstract][Full Text] [Related]
32. Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.
Macias RI
ISRN Hepatol; 2014; 2014():828074. PubMed ID: 27335842
[TBL] [Abstract][Full Text] [Related]
33. Combined gemcitabine and S-1 chemotherapy for treating unresectable hilar cholangiocarcinoma: a randomized open-label clinical trial.
Li H; Zhang ZY; Zhou ZQ; Guan J; Tong DN; Zhou GW
Oncotarget; 2016 May; 7(18):26888-97. PubMed ID: 27058753
[TBL] [Abstract][Full Text] [Related]
34. Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT).
Mizusawa J; Morizane C; Okusaka T; Katayama H; Ishii H; Fukuda H; Furuse J;
Jpn J Clin Oncol; 2016 Apr; 46(4):385-8. PubMed ID: 27025903
[TBL] [Abstract][Full Text] [Related]
35. A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract.
Graham JS; Boyd K; Coxon FY; Wall LR; Eatock MM; Maughan TS; Highley M; Soulis E; Harden S; Bützberger-Zimmerli P; Evans TR
BMC Res Notes; 2016 Mar; 9():161. PubMed ID: 26969121
[TBL] [Abstract][Full Text] [Related]
36. A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.
Mohri D; Ijichi H; Miyabayashi K; Takahashi R; Kudo Y; Sasaki T; Asaoka Y; Tanaka Y; Ikenoue T; Tateishi K; Tada M; Isayama H; Koike K
J Gastroenterol; 2016 Jul; 51(7):711-21. PubMed ID: 26614007
[TBL] [Abstract][Full Text] [Related]
37. Intrahepatic chemotherapy for unresectable cholangiocarcinoma: review of literature and personal experience.
Massani M; Nistri C; Ruffolo C; Bonariol R; Pauletti B; Bonariol L; Caratozzolo E; Morana G; Bassi N
Updates Surg; 2015 Dec; 67(4):389-400. PubMed ID: 26468142
[TBL] [Abstract][Full Text] [Related]
38. Surgical treatment for intrahepatic cholangiocarcinoma.
Uenishi T; Yamamoto T; Takemura S; Kubo S
Clin J Gastroenterol; 2014 Apr; 7(2):87-93. PubMed ID: 26183622
[TBL] [Abstract][Full Text] [Related]
39. Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer.
Sasaki T; Isayama H; Nakai Y; Ito Y; Yasuda I; Toda N; Yagioka H; Matsubara S; Hanada K; Maguchi H; Kamada H; Hasebe O; Mukai T; Okabe Y; Maetani I; Koike K
World J Gastroenterol; 2014 Dec; 20(48):18452-7. PubMed ID: 25561816
[TBL] [Abstract][Full Text] [Related]
40. Enteral stents are safe and effective to relieve malignant gastric outlet obstruction in the elderly.
Mansoor H; Zeb F
J Gastrointest Cancer; 2015 Mar; 46(1):42-7. PubMed ID: 25487197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
